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Abstract:  Busulfan, an antineoplastic bifunctional-alkylating agent, is known to induce developmental anomalies.  In
the present study, we examined the distribution and sequence of pyknotic cells in rat fetal tissues exposed to busulfan.
Pregnant rats on gestation day 13 were administered intraperitoneally 30 mg/kg of busulfan, and fetal tissues were
examined at 6, 12, 24, 36, 48, 72 and 96 hours after treatment (HAT).  Pyknosis of component cells was observed
markedly in the brain, moderately in the eyes and spinal cord and mildly in the craniofacial tissue, mandible, limb buds,
tail bud, ganglions, alimentary tract, lungs, kidneys, pancreas and liver.  In the brain, mitotic inhibition was also detected.
Most of the pyknotic cells were considered to be apoptotic cells judging from the results of TUNEL staining and electron
microscopic examination.  Commonly in the above-mentioned tissues, pyknotic cells began to increase at 24 HAT,
peaked at 36 or 48 HAT and disappeared at 96 HAT, which is when the histological picture returned to normal in most
tissues except for the brain, spinal cord and eyes.  The present study clarified the outline of busulfan-induced apoptosis
in rat fetuses.    (J Toxicol Pathol 2009; 22: 167–171)
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Introduction
Busulfan is a bifunctional alkylating agent used for
treatment of chronic myeloid leukemia.  However, busulfan is
also known to have teratogenic and cytotoxic potential1, and
it has been reported that busulfan induces microencephaly,
microphthalmia, microtia, microrostellum, micrognathia,
microabdomen, and brachydactylia in a number of animal
species2–5.  Recently, Furukawa et al.3 examined in detail the
brain and eyes of rat fetuses obtained from dams
administered 10 mg/kg/day of busulfan from gestation day
(GD) 12 to 14 and demonstrated that busulfan induces
apoptosis and mitotic inhibition in neuroepithelial cells of
the fetal brain and eyes.  They suggested that such extensive
apoptosis and mitotic inhibition might be related to the
induction of malformations in the brain and eyes.
Busulfan is easily absorbed; distributes to the spleen,
bone marrow, liver, kidneys and lungs; and rapidly
disappears from blood circulation in adults6–9.  In addition, it
has been reported that the main target of the cytotoxic effects
of busulfan is slowly proliferating or non-proliferating stem
cell compartments in such tissues as the lungs10,
gastrointestinal tissues11, lymphoid tissues12,13, gonadal
tissues4 and neural tissues11 in humans and animals.
However, there are no available data on such stem cell
compartments in fetal tissues, and the whole area of
busulfan-induced fetotoxicity has not yet been fully
elucidated.
In the present study, as a first step to clarify the
histopathological nature of busulfan-induced fetotoxicity,
histopathological examinations were carried out on fetal
tissues obtained from dams exposed to busulfan on GD 13,
focusing on the distribution and sequence of pyknotic cells.
In addition, we attempted to compare busulfan-induced
central nervous system (CNS) lesions with other DNA-
damaging agents-induced lesions.  In this connection, GD 13
has been reported to be the most sensitive period of the rat
fetal CNS to DNA-damaging agents14–19.
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Materials and Methods
Animals
Forty-two pregnant Crl:CD (SD) rats on GD 10 were
obtained from Charles River Japan Inc. (Kanagawa, Japan).
The animals were housed individually in plastic cages in an
environmentally controlled room (temperature: 23 ± 3°C;
relative humidity: 55 ± 20%; ventilation rate: 10–15 times
per hour; and 12h/12h light /dark cycle) and fed a
commercial diet (CRF-1; Oriental Yeast Co., Ltd., Tokyo,
Japan) and tap water ad libitum.  The protocol of this study
was reviewed and approved by the Animal Care and Use
Committee of Bozo Research Center.
Chemical and dosage
Busulfan (Sigma, St. Louis, MO, USA) was suspended
with olive oil.  The dose (30 mg/kg) of busulfan used in the
present study was determined based on the results of a
preliminary study, in which dams were administered
intraperitoneally busulfan at a single dose of 10, 30 or 50
mg/kg on GD 13.
Experimental designs
Forty-two animals were equally divided into the control
and busulfan groups.  The animals of the busulfan group
were administered intraperitoneally 30 mg/kg of busulfan,
and those of the control group were administered
intraperitoneally 10 mL/kg of olive oil on GD 13.  Three
dams of each group were sacrificed by exsanguination from
the abdominal aorta under diethyl ether anesthesia at 6, 12,
24, 36, 48, 72 and 96 hours after busulfan-treatment (HAT),
respectively.  At necropsy, the body weights of dams and
fetuses and litter sizes were recorded.
Histopathology
All fetuses were weighed and fixed with 10%
phosphate-buffered formalin (pH 7.2).  A total of 10 fetuses
each of the control and busulfan groups were obtained
randomly from dams at each time-point (3 or 4 fetuses/dam).
Four-μm paraffin sections were stained with hematoxylin
and eosin (HE) and subjected to histopathological
examinations.
In situ detection of fragmented DNA
DNA fragmentation was examined by the terminal
deoxynucleotidyl transferase-mediated dUTP end labeling
(TUNEL) method, which was first proposed by Gavrieli et
al.20 and has been widely used for the detection of apoptotic
cells, using a commercial apoptosis detection kit (Chemicon
Inc., Gaithersburg, MD, USA).  In brief, multiple
fragmentation DNA3’-OH ends on the section were labeled
with digoxigenin-dUTP in the presence of terminal
deoxynucleotidyl transferase (TdT).  Peroxidase-conjugated
anti-digoxigenin antibody was then reacted with the
sections.  Apoptotic nuclei were visualized by peroxidase-
diaminobenzidine (DAB) reaction.  The sections were then
counterstained with methyl green.
Electron microscopy
Small pieces of the telencephalic wall (2 fetuses each
from 2 dams of the control and busulfan groups) were
obtained at 48 HAT.  They were fixed in 0.5%
glutaraldehyde/1.5% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.4), postfixed in 1% osmium tetroxide in the
same buffer and embedded in epoxy resin (Nissin EM Co.,
Ltd., Tokyo, Japan).  Ultrathin sections of the selected
blocks were double-stained with uranyl acetate and lead
citrate and observed under a JEM-100CXII electron
microscope (JEOL Ltd., Tokyo, Japan).
Statistical analysis
Numerical data were expressed as the Mean ± standard
deviation (SD).  For the numerical data, the homogeneity of
variance in the control and busulfan groups were analyzed
by the F test (level of significance: 5%, two-tailed), and the
homogeneous data were analyzed by the Student’s t-test
(level of significance: 1%, two-tailed), while the
heterogeneous data were analyzed by the Aspin-Welch t-test
(level of significance: 1%, two-tailed) for the group mean
difference between the control and busulfan groups.
Results
Mortality, bodyweights of dams and fetuses and litter
size
No deaths occurred in any dams of the control and
busulfan groups.  The body weights of the dams in the
busulfan group were reduced from 24 to 96 HAT compared
with those in the control group, but there were no significant
differences between the two groups (Fig. 1).  There were no
Fig. 1. Changes in the body weights of dams and litter size.  :
Control group.  : Busulfan group.  n: Number of dams.
Body weight is shown as the mean ± SD.Ohira, Ando, Andoh et al. 169
differences in litter size between the control and busulfan
groups (Fig 1).  The fetal body weights of the busulfan group
were significantly reduced at 72 and 96 HAT compared with
those of the control group (Fig. 2).
Histopathological changes
In the busulfan group, pyknotic cells were observed
markedly in the brain (telencephalon, diencephalon,
mesencephalon and metencephalon), moderately in the eyes
(retina and lens) and spinal cord (dorsal layer) and mildly in
the mesenchymal cells of the craniofacial tissues, mandible,
limb buds and tail bud, dorsal root ganglions, epithelial cells
of the alimentary tract, lungs, kidneys and pancreas, and
hepatocytes and hematopoietic progenitor cells were
observed in the liver (Table 1 and Figs.3 and 4).  The
sequence of pyknotic cells was similar among the tissues
affected, and the pyknotic cells began to increase at 24 HAT,
peaked at 36 or 48 HAT and disappeared at 96 HAT (Table
1).  For example, in the telencephalic wall (Fig. 5), a few
pyknotic cells appeared mainly in the medial layer of the
ventricular zone (VZ) at 24 HAT.  At 36 HAT, pyknotic cells
drastically increased in number in all layers of the VZ except
for one or two cell layers facing the ventricle and in the
cortical plate (CP).  At 48 HAT, the density of neuroepithelial
cells was reduced due to disappearance of dead cells, leaving
irregular empty space in the VZ.  From 36 to 48 HAT, the
number of mitotic cells in the ventricular layer of the VZ was
reduced in the busulfan group compared with the control
group.  At 72 HAT, pyknotic cells decreased, but still
remained in the medial and dorsal layers of the VZ.  At 96
HAT, pyknotic cells were no longer observed.
At 96 HAT, the histological picture returned to normal
in most tissues except for the brain, spinal cord and eyes.  In
particular, the width of the VZ of the brain and dorsal layer
of the spinal cord and the retinal thickness and lenticular size
Fig. 2. Changes in fetal weights.   : Control group.  : Busulfan
group.  Fetal weight is shown as the mean ± SD.  *p<0.01:
Significantly different from the control group.
Table 1. Distribution and Sequence of Pyknotic Cells in Rat Fetal Tissues Exposed to Busulfan
Control     0 mg/kg Busulfan    30 mg/kg
H o u r s  a f t e r  t r e a t m e n t 6 1 22 43 64 87 29 661 2 2 43 64 87 2 9 6
Central nervous system
Telencephalon – – – – – – – – – + +++ +++ ++ –
Diencephalon – – – – – – – – – + + ++ + –
Mesencephalon – – – – – – – – – + + ++ + –
Metencephalon – – – – – – – – – + ++ ++ ± –
S p i n a l  c o r d ––––––– – – + + + + + ± –
Mesenchymal tissues – – – – – – – – – + + + ± –
Craniofacial – – – – – – – – – + + + ± –
Mandible – – – – – – – – – ± ++± –
L i m b  b u d s ––––––– – – +++± –
T a i l  b u d ––––––– – – ± ++± –
Spinal ganglion – – – – – – – – – ± + ±± –
Alimentary tract – – – – – – – – – ± ++± –
H e a r t ––––––– – – –––– –
Lungs – – – – – – – – – ± ++± –
Kidneys – – – – – – – – – ±±±± –
P a n c r e a s ––––––– – – ±±±––
L i v e r ––––––– – – ± ++– –
Hematopoietic cells in the liver – – – – – – – – – ± ++± –
Eyes
R e t i n a – – – – – – –––++ + + ++ –
L e n s ––––––– – – –++± –
Codes: –, ±, +, ++ and +++ indicate almost absent, minimal, mild, moderate and marked, respectively.170 Busulfan-induced Pyknosis in Rat Fetuses
of the eyes were reduced in comparison with those of the
controls.
The nuclei of almost all of the pyknotic cells were
positively stained by the TUNEL method (Fig. 6).  Moreover,
in the electron microscopic examination, pyknotic cells
showed shrinkage of the cell body with nuclear chromatin
condensation, and some of the cells were fragmented into so-
called apoptotic bodies, which were frequently ingested by
adjacent cells and macrophages (Fig. 7).
Discussion
In the present study, the distribution and sequence of
pyknotic cells were examined in fetal tissues obtained from
dams intraperitoneally treated with 30 mg/kg of busulfan on
GD 13.
No deaths occurred in any dams and fetuses, and there
was no difference in litter size between the control and
busulfan groups.  However, compared with those of the
control group, the fetal weights of the busulfan group were
significantly reduced at 72 and 96 HAT.
The histopathological changes in the brain and eyes
roughly corresponded to those reported by Furukawa et al.3
Moreover, in the present study, pyknosis was also detected
in the component cells of the spinal cord, craniofacial tissue,
mandible, limb buds, tail bud, ganglion, alimentary tract,
lungs, kidneys, pancreas and liver.  Apart from their severity,
the sequence of pyknotic cells was similar among the above-
mentioned tissues.  Namely, pyknotic cells generally began
to increase at 24 HAT, peak at 36 or 48 HAT and
disappeared at 96 HAT, when the histological picture
returned to normal in most tissues except for the brain, spinal
cord and eyes, in which histopathological changes such as
reduction in size and cell density remained.  In the brain,
which was most severely damaged, a decrease in the number
of mitotic cells located in the ventricular layer of the VZ was
also detected.  This suggests that apoptosis and growth
inhibition of neuroepithelial cells occurred simultaneously in
the busulfan group as previous reported in rat and mouse
fetal brains exposed to other DNA damaging agents14–19, 21.
The difference in the severity of pyknosis of component cells
among the fetal tissues in the present study is considered to
reflect the difference in the stage of their development on the
day of busulfan exposure.
The nuclei of almost all of the above-mentioned
pyknotic cells were positively stained by the TUNEL
method.  Moreover, these pyknotic cells showed electron
microscopic characteristics of apoptotic cells.  Therefore, it
is reasonable to consider that these pyknotic cells were
apoptotic.  Thus, excessive apoptotic cell death induced in
the above-mentioned fetal tissues by busulfan may result in
induction of malformation in the corresponding tissues of
neonates as mentioned previously.
The induction of apoptotic cell death in the CNS has
also been reported for DNA-damaging agents such as 5-
azacytidine16,22, ethylnitrosourea14, 1-β-D-
arabinofuranosylcytosine15, indole-3-acetic acid23,
etoposide17, 5-fluorouracil18, 6-mercaptopurine21 and
hydroxyurea19, suggesting that the fetal CNS might be
highly sensitive to genotoxic agents.  The histopathological
findings in the fetal CNS were essentially similar between
the present data on busulfan and those on the above-
mentioned chemicals.  However, the timing of the peak
apoptotic cell number was clearly delayed in the cases of
busulfan and 6-mercaptopurin21 than in the cases of other
chemicals, although the cause of this difference is still
unknown.
The detailed mechanisms of apoptotic cell death and
cell cycle arrest induced in the fetal brain are considered to
be different among DNA-damaging agents24–27.  In addition,
the exact mechanisms of busulfan-induced cytotoxicity in
the fetal CNS remains unclear.  The present results may
provide not only fundamental information about systemic
fetal tissue damage by busulfan but also a clue for
elucidating the exact mechanisms of busulfan-induced
cytotoxicity, especially in the fetal brain.
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Fig. 7. Ultrastrusture of pyknotic cells in the telencephalon at 48
HAT.  Condensation of the nuclear chromatin of
neuroepithelial cells and phagocytosis of apoptotic bodies
by macrophages are shown. Bar=10 μm.